CARTER'S INC (CRI) Fundamental Analysis & Valuation

NYSE:CRI • US1462291097

Current stock price

34.63 USD
-0.44 (-1.25%)
At close:
34.63 USD
0 (0%)
After Hours:

This CRI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. CRI Profitability Analysis

1.1 Basic Checks

  • In the past year CRI was profitable.
  • CRI had a positive operating cash flow in the past year.
  • CRI had positive earnings in 4 of the past 5 years.
  • CRI had a positive operating cash flow in 4 of the past 5 years.
CRI Yearly Net Income VS EBIT VS OCF VS FCFCRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

  • CRI has a Return On Assets (3.52%) which is in line with its industry peers.
  • The Return On Equity of CRI (10.06%) is better than 62.22% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 6.89%, CRI is in line with its industry, outperforming 60.00% of the companies in the same industry.
  • CRI had an Average Return On Invested Capital over the past 3 years of 13.75%. This is above the industry average of 11.73%.
  • The last Return On Invested Capital (6.89%) for CRI is well below the 3 year average (13.75%), which needs to be investigated, but indicates that CRI had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.52%
ROE 10.06%
ROIC 6.89%
ROA(3y)9.05%
ROA(5y)8.18%
ROE(3y)26.4%
ROE(5y)25.22%
ROIC(3y)13.75%
ROIC(5y)13.22%
CRI Yearly ROA, ROE, ROICCRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • The Profit Margin of CRI (3.07%) is comparable to the rest of the industry.
  • CRI's Profit Margin has declined in the last couple of years.
  • CRI has a Operating Margin of 6.09%. This is comparable to the rest of the industry: CRI outperforms 55.56% of its industry peers.
  • In the last couple of years the Operating Margin of CRI has declined.
  • The Gross Margin of CRI (46.79%) is comparable to the rest of the industry.
  • CRI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.09%
PM (TTM) 3.07%
GM 46.79%
OM growth 3Y-11.06%
OM growth 5Y-2.63%
PM growth 3Y-12.75%
PM growth 5Y-2.95%
GM growth 3Y0.38%
GM growth 5Y2.29%
CRI Yearly Profit, Operating, Gross MarginsCRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CRI Health Analysis

2.1 Basic Checks

  • CRI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • There is no outstanding debt for CRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRI Yearly Shares OutstandingCRI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CRI Yearly Total Debt VS Total AssetsCRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.66 indicates that CRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of CRI (2.66) is comparable to the rest of the industry.
  • CRI has a debt to FCF ratio of 5.42. This is a neutral value as CRI would need 5.42 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 5.42, CRI perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
  • CRI has a Debt/Equity ratio of 0.58. This is a neutral value indicating CRI is somewhat dependend on debt financing.
  • CRI has a worse Debt to Equity ratio (0.58) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 5.42
Altman-Z 2.66
ROIC/WACC0.66
WACC10.49%
CRI Yearly LT Debt VS Equity VS FCFCRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 2.26 indicates that CRI has no problem at all paying its short term obligations.
  • CRI has a better Current ratio (2.26) than 64.44% of its industry peers.
  • CRI has a Quick Ratio of 2.26. This is a bad value and indicates that CRI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CRI's Quick ratio of 0.95 is in line compared to the rest of the industry. CRI outperforms 44.44% of its industry peers.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 0.95
CRI Yearly Current Assets VS Current LiabilitesCRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CRI Growth Analysis

3.1 Past

  • The earnings per share for CRI have decreased strongly by -42.83% in the last year.
  • The Earnings Per Share has been decreasing by -3.52% on average over the past years.
EPS 1Y (TTM)-42.83%
EPS 3Y-20.55%
EPS 5Y-3.52%
EPS Q2Q%-26.64%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.65%

3.2 Future

  • Based on estimates for the next years, CRI will show a small growth in Earnings Per Share. The EPS will grow by 1.01% on average per year.
  • The Revenue is expected to grow by 2.02% on average over the next years.
EPS Next Y-10.55%
EPS Next 2Y1.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.12%
Revenue Next 2Y1.44%
Revenue Next 3Y2.02%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CRI Yearly Revenue VS EstimatesCRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CRI Yearly EPS VS EstimatesCRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. CRI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.98 indicates a reasonable valuation of CRI.
  • Based on the Price/Earnings ratio, CRI is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
  • CRI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.96.
  • Based on the Price/Forward Earnings ratio of 11.16, the valuation of CRI can be described as reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CRI indicates a somewhat cheap valuation: CRI is cheaper than 80.00% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.04. CRI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.98
Fwd PE 11.16
CRI Price Earnings VS Forward Price EarningsCRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 80.00% of the companies in the same industry are more expensive than CRI, based on the Enterprise Value to EBITDA ratio.
  • 75.56% of the companies in the same industry are more expensive than CRI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.7
EV/EBITDA 7
CRI Per share dataCRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.01%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. CRI Dividend Analysis

5.1 Amount

  • CRI has a Yearly Dividend Yield of 2.89%.
  • Compared to an average industry Dividend Yield of 1.48, CRI pays a better dividend. On top of this CRI pays more dividend than 82.22% of the companies listed in the same industry.
  • CRI's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 2.89%

5.2 History

  • On average, the dividend of CRI grows each year by 16.75%, which is quite nice.
  • CRI has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CRI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)16.75%
Div Incr Years1
Div Non Decr Years4
CRI Yearly Dividends per shareCRI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 87.45% of the earnings are spent on dividend by CRI. This is not a sustainable payout ratio.
  • The dividend of CRI is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP87.45%
EPS Next 2Y1.01%
EPS Next 3YN/A
CRI Yearly Income VS Free CF VS DividendCRI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
CRI Dividend Payout.CRI Dividend Payout, showing the Payout Ratio.CRI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CRI Fundamentals: All Metrics, Ratios and Statistics

CARTER'S INC

NYSE:CRI (3/17/2026, 4:27:21 PM)

After market: 34.63 0 (0%)

34.63

-0.44 (-1.25%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)02-27
Earnings (Next)04-23
Inst Owners115.64%
Inst Owner Change1.79%
Ins Owners2.8%
Ins Owner Change13.26%
Market Cap1.26B
Revenue(TTM)N/A
Net Income(TTM)87.00M
Analysts49.23
Price Target35.5 (2.51%)
Short Float %9.86%
Short Ratio2.56
Dividend
Industry RankSector Rank
Dividend Yield 2.89%
Yearly Dividend3.2
Dividend Growth(5Y)16.75%
DP87.45%
Div Incr Years1
Div Non Decr Years4
Ex-Date03-13
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-28.64%
Min EPS beat(2)-56.97%
Max EPS beat(2)-0.32%
EPS beat(4)2
Avg EPS beat(4)-0.02%
Min EPS beat(4)-56.97%
Max EPS beat(4)33.81%
EPS beat(8)6
Avg EPS beat(8)13.85%
EPS beat(12)10
Avg EPS beat(12)20.28%
EPS beat(16)12
Avg EPS beat(16)15.61%
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-2.52%
Max Revenue beat(2)2.56%
Revenue beat(4)2
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-2.52%
Max Revenue beat(4)2.56%
Revenue beat(8)3
Avg Revenue beat(8)-0.06%
Revenue beat(12)5
Avg Revenue beat(12)0.69%
Revenue beat(16)7
Avg Revenue beat(16)0.1%
PT rev (1m)4.19%
PT rev (3m)17.97%
EPS NQ rev (1m)8.73%
EPS NQ rev (3m)26.07%
EPS NY rev (1m)3.33%
EPS NY rev (3m)12.24%
Revenue NQ rev (1m)0.99%
Revenue NQ rev (3m)3.9%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)1.21%
Valuation
Industry RankSector Rank
PE 9.98
Fwd PE 11.16
P/S 0.44
P/FCF 13.7
P/OCF 8.34
P/B 1.46
P/tB 3.44
EV/EBITDA 7
EPS(TTM)3.47
EY10.02%
EPS(NY)3.1
Fwd EY8.96%
FCF(TTM)2.53
FCFY7.3%
OCF(TTM)4.15
OCFY11.99%
SpS77.84
BVpS23.76
TBVpS10.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number43.07
Profitability
Industry RankSector Rank
ROA 3.52%
ROE 10.06%
ROCE 8.76%
ROIC 6.89%
ROICexc 7.6%
ROICexgc 10.55%
OM 6.09%
PM (TTM) 3.07%
GM 46.79%
FCFM 3.25%
ROA(3y)9.05%
ROA(5y)8.18%
ROE(3y)26.4%
ROE(5y)25.22%
ROIC(3y)13.75%
ROIC(5y)13.22%
ROICexc(3y)16.52%
ROICexc(5y)18.31%
ROICexgc(3y)24.79%
ROICexgc(5y)28.26%
ROCE(3y)17.48%
ROCE(5y)16.81%
ROICexgc growth 3Y-19.15%
ROICexgc growth 5Y0.36%
ROICexc growth 3Y-17.36%
ROICexc growth 5Y-0.7%
OM growth 3Y-11.06%
OM growth 5Y-2.63%
PM growth 3Y-12.75%
PM growth 5Y-2.95%
GM growth 3Y0.38%
GM growth 5Y2.29%
F-Score5
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 5.42
Debt/EBITDA 2.19
Cap/Depr 107.95%
Cap/Sales 2.09%
Interest Coverage 250
Cash Conversion 66.51%
Profit Quality 105.72%
Current Ratio 2.26
Quick Ratio 0.95
Altman-Z 2.66
F-Score5
WACC10.49%
ROIC/WACC0.66
Cap/Depr(3y)84.08%
Cap/Depr(5y)65.4%
Cap/Sales(3y)1.75%
Cap/Sales(5y)1.49%
Profit Quality(3y)119.52%
Profit Quality(5y)187.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-42.83%
EPS 3Y-20.55%
EPS 5Y-3.52%
EPS Q2Q%-26.64%
EPS Next Y-10.55%
EPS Next 2Y1.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.65%
Revenue Next Year2.12%
Revenue Next 2Y1.44%
Revenue Next 3Y2.02%
Revenue Next 5YN/A
EBIT growth 1Y-52.45%
EBIT growth 3Y-16.9%
EBIT growth 5Y-6.69%
EBIT Next Year-12.05%
EBIT Next 3Y1.51%
EBIT Next 5Y6.82%
FCF growth 1Y-79.82%
FCF growth 3Y1.66%
FCF growth 5Y-5.73%
OCF growth 1Y-70.46%
OCF growth 3Y3.65%
OCF growth 5Y-5.05%

CARTER'S INC / CRI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CARTER'S INC (CRI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CRI.


What is the valuation status of CARTER'S INC (CRI) stock?

ChartMill assigns a valuation rating of 6 / 10 to CARTER'S INC (CRI). This can be considered as Fairly Valued.


What is the profitability of CRI stock?

CARTER'S INC (CRI) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for CRI stock?

The Price/Earnings (PE) ratio for CARTER'S INC (CRI) is 9.98 and the Price/Book (PB) ratio is 1.46.


How financially healthy is CARTER'S INC?

The financial health rating of CARTER'S INC (CRI) is 4 / 10.